India's pharmaceutical exports are on the rise. The country's exports grew by 9.4 percent in 2024–25, reaching USD 30.47 billion. The government's push to expand India's global presence in medicines was discussed in New Delhi this Saturday. This initiative reflects the commitment of Prime Minister Narendra Modi to improve the industry through better coordination.

What Happened?

During a recent meeting titled “Scaling up Pharma Exports,” officials highlighted the strong growth of India's pharmaceutical sector. This sector is currently valued at around USD 60 billion and is expected to grow to USD 130 billion by 2030. The Ministry of Commerce and Industry confirmed that India's pharmaceutical exports are already making a mark on the global stage.

India is the third largest producer of medicines globally. Over 200 countries receive pharmaceutical products from India, with more than 60 percent going to highly regulated markets. The United States leads these exports, accounting for 34 percent, followed by Europe at 19 percent. The Commerce Secretary stressed the importance of engaging with industry players to tackle challenges faced in these markets.

Key Highlights

India's pharmaceutical exports grew by 9.4 percent to reach USD 30.47 billion in 2024–25.
The government aims for double-digit growth in the pharmaceutical sector by 2026–27.
India's pharmaceutical industry could reach USD 130 billion by 2030.
India ranks third globally in terms of the volume of medicines produced.
The U.S. and Europe are key markets, receiving over 50 percent of India's exports.
Efforts are being made to simplify regulations and improve export processes.
The Biopharma SHAKTI initiative will focus on biologics and biosimilars for better healthcare.

Why Does This Matter?

This news is essential because it shows India's commitment to becoming a significant player in the global pharmaceutical market. More exports mean that India can provide affordable and high-quality medicines to people around the world. This is crucial for public health, particularly in low and middle-income countries where access to medicines remains a challenge.

Moreover, the growth in the pharmaceutical sector can create more jobs in India. With better support for small and medium enterprises, more businesses can thrive, leading to economic growth. Ultimately, this commitment reflects how India aims to strengthen its global trade partnerships.

What Are People Saying?

What Happens Next?

Frequently Asked Questions (FAQ)